FGF2 is a growth factor that activates fibroblast growth factor receptor 1 (FGFR1), expressed on AML blasts, to promote downstream MAPK signaling independent of FLT3 [65], and has been implicated in resistance to quizartinib [70]. Here, FLT3 is linked to acute myeloid leukemia.